IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AARON DIDICH who wrote (968)	6/8/1997 11:03:00 AM
From: Brad C. Dunlap	of 1762

Wow, that is certainly interesting as I have not seen the article. $100 million in earnings is a very aggressive number and would translate into approx $3.92 per share and at a 30 p/e would value the stock around $ 117/sh. Of course proper analysis would lower this number for the r&d and expenses of the other products. Could you double check the article and make sure it was 100 mill in earnings or Revenue. Also, is this the amount that would accrue to Idec or the total amount for C2B8 that must be shared with Genentech in the USA and Roche for sales in Europe. Either way I appreciate you bringing this to our attention. It's amazing, I let my subscription to Financial World lapse as of the last issue and just in the nick of time to miss the article.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next